Company: AGIO
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001439222-25-000089
Chunk: 130

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-07-31
Form: 10-Q
Item: Part I, Item 1
Chunk 130
---
 weighted-average period of approximately 2.10 years.

13

Performance-based stock units The following table presents PSU activity for the six months ended June 30, 2025:Number ofStock UnitsWeighted-AverageGrant Date Fair ValueUnvested shares at December 31, 2024374,583 $29.45 Granted185,450 33.25 Vested(83,027)26.35 Unvested shares at June 30, 2025477,006 $31.47 Stock-based compensation expense associated with these PSUs is recognized if the underlying performance condition is considered probable of achievement using our management’s best estimates.As of June 30, 2025, there was no unrecognized compensation expense related to PSUs with performance-based vesting criteria that are considered probable of achievement, and $15.0 million of total unrecognized compensation expense related to PSUs with performance-based vesting criteria that are considered not probable of achievement.2013 Employee Stock Purchase PlanIn June 2013, our Board of Directors adopted, and in July 2013 our stockholders approved, the 2013 Employee Stock Purchase Plan, or the 2013 ESPP. We issued and sold 52,092 and 52,514 shares of common stock during the six months ended June 30, 2025 and 2024, respectively, under the 2013 ESPP. The 2013 ESPP provides participating employees with the opportunity to purchase up to an aggregate of 2,363,636 shares of our common stock. As of June 30, 2025, we had 1,531,142 shares of common stock available for future issuance under the 2013 ESPP.Stock-based compensation expenseStock-based compensation expense by award type included within the condensed consolidated statements of operations is as follows:Three Months EndedJune 30,Six Months EndedJune 30,(In thousands)2025202420252024Stock options$4,622 $4,361 $9,022 $8,432 Restricted stock units7,507 6,211 14,191 11,177 Performance-based stock units2,188 750 2,188 750 Employee stock purchase plan375 243 650 440 Total stock-based compensation expense$14,692 $11,565 $26,051 $20,799 Expenses related to stock options and stock-based awards were allocated as follows